COVID-19: Pfizer announces 520 mln euros investment plan in France
- Country:
- France
Albert Bourla, the chief executive of U.S. drugmaker company Pfizer, told French TV station BFM TV on Monday that Pfizer was making a 520 million euros ($593.7 million) investment plan in France over 5 years to help tackle COVID-19. Pfizer CEO Bourla also told BFM TV that Pfizer was setting up a partnership with French company Novasep to develop an anti-COVID pill treatment.
($1 = 0.8758 euros)
ALSO READ
-
Morepen Hits Record Q2FY27 Revenue of Rs. 755 Cr; Driven by CDMO Momentum, EBITDA Surges 273% to Rs. 132 Cr in Q2FY27 and Rs. 220 Cr. in H1FY27
-
Nearly one in five Women's Indian Open players have US Kids Golf roots
-
Instagram tests 90-minute horizontal videos
-
PV Sindhu to lead India’s campaign at Hylo Open 2026 after French Open runner-up finish; Lakshya Sen also in action
-
"Bhagwant Mann has reduced Punjab to Gunda Raj and Jungle Raj": BJP's Gaurav Bhatia attacks AAP
Google News